Meet the Team

Real Strength Starts With Real Support

Real strength starts from within the team. Here’s how your Galatea team defines real strength within their own lives.

Kristin Crescenzi

Director of Marketing and NPD

Quinn Mentone

U.S. Regional Manager – West

Trent Newell

U.S. Regional Manager – East

Adrian Roji

SVP and GM

Lauren Wohlwend

Territory Manager

West and Central FL

Robert Waldowski

Territory Manager

Pittsburgh, OH, IN, MI, NY, Canada

Candice Walsh

Territory Manager

GA, KY, TN, AL, MS

Alysha Totemwongs

Territory Manager

NC, SC, SoVA, W VA

Craig Overby

Territory Manager

North TX, OK, LA, AR

Amanda Swanson

Territory Manager

AZ, NM, CO, NV

Mike Clancy

Territory Manager

SoFl

Danell Zalwski

Territory Manager

Orange Country, San Diego, Inland Empire

Julie Davenport

Territory Manager

Los Angeles, UT

Megan Jo Noble

Territory Manager

IL, MO, KS

Sean Moritz

Territory Manager

SoTX, SoLA

Amanda Perschau

Territory Manager

No VA, DC, MD, NJ, Philadelphia

Justin Pessa

Sr Marketing Manager

Elena Casado

Director of International Marketing

Ignasi Vivas

SVP and GM – International

Indications for Use

GalaFLEX, GalaFLEX 3D and GalaFLEX 3DR scaffolds are indicated for use as bioresorbable scaffolds for soft tissue support and to repair, elevate, and reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome. This includes reinforcement of soft tissue in plastic and reconstructive surgery, and general soft tissue reconstruction. These products, referred to as Galatea scaffolds, are also indicated for the repair of fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.

Important Safety Information

Possible complications following implantation of Galatea scaffolds include infection, seroma, pain, scaffold migration, wound dehiscence, hemorrhage, adhesions, hematoma, inflammation, extrusion and recurrence of the soft tissue defect. The safety and product use of Galatea scaffolds for patients with hypersensitivities to the antibiotics kanamycin sulfate and tetracycline hydrochloride is unknown. Galatea scaffolds have not been studied for use in breast reconstructive surgeries. The safety and effectiveness of Galatea scaffolds in neural tissue and in cardiovascular tissue has not been established. The safety and effectiveness of Galatea scaffolds in pediatric use has not been established. Consult the specific Galatea scaffold Instructions for Use for complete prescribing information, including its indications for use, warnings and precautions.

500167 Rev A